INTERMITTENT HYPOXIC TRAINING
Intermittent Hypoxic Training: Adaptation by Design.
Brief, repeated drops in blood oxygen trigger adaptations the body would otherwise only make at altitude. The breath is the tool.
THE BASICS
The adaptive physiology of altitude, produced through breath holds
Endurance athletes have trained at altitude for decades because reduced oxygen levels trigger adaptive changes — more red blood cells, improved oxygen delivery, better tissue efficiency — that persist long after they return to sea level. Intermittent hypoxic training applies that same principle in controlled, repeated doses.
Breath holds produce the same cascade. Ancient yogic practice established the method.
The research has since documented why it works.
WHAT IHT IS
Short exposures to reduced oxygen, alternated with recovery
In clinical and research settings, IHT is delivered using a hypoxicator or altitude chamber that reduces inspired oxygen to around 10–12% — equivalent to being at 4,000–6,000 metres. The protocol is structured: a few minutes of reduced oxygen, followed by a few minutes of normal air, repeated over a session.
The alternation matters. Sustained hypoxia causes damage. Brief, repeated dips in blood oxygen — separated by recovery intervals — produce an adaptive response instead. The body reads the fluctuation as a signal that it needs to upgrade its oxygen delivery systems.
That signal runs through a single protein called Hypoxia-Inducible Factor 1, or HIF-1. When oxygen falls, HIF-1 activates. The downstream effects follow from there.
THE PHYSIOLOGY
What HIF-1 activates
HIF-1 is a transcription factor — a molecular switch that turns on a co-ordinated set of adaptive responses when cells detect low oxygen. Here's what it initiates.
More red blood cells. HIF-1 stimulates erythropoietin (EPO) production, which signals the bone marrow to produce additional red blood cells, increasing the blood's oxygen-carrying capacity. This is the same mechanism behind altitude training — and behind doping with synthetic EPO.
New blood vessel formation. HIF-1 activates growth factors that trigger angiogenesis — the development of new vascular pathways. Blood supply to tissues improves. Research has observed this in cardiac tissue, including in people with existing heart disease, where new collateral vessels have been shown to form following repeated hypoxic exposure.
Nitric oxide production. HIF-1 induces nitric oxide synthase, increasing nitric oxide — the same molecule produced during nasal breathing and discussed on the Functional Breathing page. Nitric oxide protects cells from oxidative stress and triggers vasodilation, opening blood flow to tissues and organs.
DNA protection. Tumour protein p53 — sometimes called the guardian of the genome — is also induced under hypoxia. It protects DNA integrity and plays a central role in preventing cellular mutation.
Stem cell mobilisation. Stem cells are well-adapted to low-oxygen environments. They're abundant in fetal circulation where oxygen is low, and in adults they reside in specialised niches in the bone marrow. Research in animal models has found that mesenchymal stem cell counts in peripheral blood can increase by as much as fifteen times under hypoxic conditions. The hypothesis is that intermittent hypoxia draws these cells out of their niches and into circulation, where they can travel to sites of tissue damage and support repair.
HIF-1 controls oxygen delivery through angiogenesis and drives metabolic adaptation to hypoxia — a mechanism relevant well beyond the cancer context in which it has been most extensively studied.
COGNITIVE BENEFITS
What this means for the brain
Neural stem cells — the progenitor cells from which new neurons develop — proliferate under hypoxia. HIF-1 activates pathways that promote their division in low-oxygen environments within the brain, a process called neurogenesis.
Animal studies have demonstrated improved memory following intermittent hypoxic exposure, and there's preliminary evidence suggesting protective effects against the kind of cell degeneration associated with Alzheimer's and Parkinson's disease.
IHT also increases blood flow to the brain through the same vasodilation and angiogenic mechanisms that operate in the rest of the body. For people doing cognitively demanding work, that combination — neurogenesis, improved cerebral circulation, and the downstream effects of better oxygenation — may make IHT one of the more interesting performance tools that most practitioners haven't considered.
Intermittent hypoxia promotes neurogenesis through activation of neural stem cell proliferation, and has been associated with improvements in memory and cognitive function in animal models.
BREATH-BASED IHT
Nisshesha Rechaka — the ancient method, and why it achieves the same effects
The physiological target — a controlled drop in blood oxygen saturation — is achievable through breath holds after a full exhale. Equipment optional.
In pranayama, this practice is called Nisshesha Rechaka. The yogis who developed it were working empirically rather than from biochemical knowledge, but the method produces the same HIF-1 cascade that altitude chambers and hypoxicators are designed to trigger.
After a complete exhale, residual oxygen in the lungs and blood continues to be consumed by metabolic processes. Saturation falls. In a trained practitioner, a breath hold after full exhale can reach the hypoxic threshold within 60–90 seconds. Maintaining that state for 2–3 minutes — which experienced practitioners can do — sits within the range that hypoxic chambers are designed to achieve.
When holds after inhalation (Antara Kumbhaka) are combined with holds after exhalation (Bahya Kumbhaka) in a structured protocol — as in SOMA Breath methodology and advanced pranayama — the result is an alternating pattern of elevated and reduced blood oxygen that mirrors the structure of clinical IHT. The physiology is the same. The tool is the breath.
This is why breath-hold work sits in a supervised, progressive context. The effects are real and require appropriate preparation.
Nisshesha rechaka pranayama produces brief intermittent hypoxia and engages adaptive mechanisms consistent with those documented in machine-based hypoxic training.
THE CO₂ CONNECTION
Building on the foundation
IHT sits at the advanced end of the progression that begins with functional breathing. The sequence is sequential for a physiological reason.
The drive to breathe during a breath hold comes primarily from rising CO₂, not falling oxygen. Someone with low CO₂ tolerance will break the hold well before they reach the oxygen levels where HIF-1 activates. CO₂ tolerance training — progressively extending comfort with elevated CO₂ — is what makes longer holds possible and, through that, what makes genuine hypoxic adaptation accessible.
The chain runs: functional breathing → improved CO₂ tolerance → extended breath holds → hypoxic threshold reached → HIF-1 activation → adaptive cascade.
The Functional Breathing page covers where that chain starts.
WHO THIS IS FOR
People who have built the foundation
IHT is appropriate for people who have established nasal diaphragmatic breathing as their default, worked progressively on CO₂ tolerance, and have measurable breath-hold capacity — typically a BOLT score above 25. Practitioner supervision is required.
Without the foundational preparation, hypoxic training produces discomfort without the corresponding adaptation. In people with certain health conditions, it carries real risk.
This page is here to explain the science. Supervised practice is what comes next.
Safety and Contraindications - who should not do this work
The following are contraindications to IHT and breath-hold protocols. This is not an exhaustive list and does not replace medical clearance.
Cardiovascular conditions — hypertension, arrhythmias, heart disease, or any history of stroke or TIA. The demands of breath holds can interact dangerously with compromised cardiac function.
Respiratory disorders — COPD, moderate-to-severe asthma, or other conditions affecting lung function.
Neurological conditions — epilepsy or any history of seizures. Hypoxia is a known trigger in susceptible individuals.
Pregnancy — the oxygen requirements of the fetus make hypoxic training contraindicated.
Severe anemia and blood disorders — reduced haemoglobin means hypoxic exposure carries a disproportionate physiological burden.
Severe anxiety or panic disorders — the sensation of rising CO₂ during a breath hold can trigger hyperarousal and panic responses. This applies specifically to hypoxic training, not to all breathwork.
Recent surgery or acute injury — particularly any procedure or injury involving the heart, lungs, brain, or vascular system.
If any of the above apply, or if there's any uncertainty about health status, medical clearance is required before attempting breath-hold protocols.
WHY THIS MATTERS
A genuine differentiator — the full arc of the work
Most breathwork practitioners don't engage with IHT. Among those who do, few ground it in the physiology that explains what it actually produces and why.
This page covers the advanced end of a progression that begins with functional breathing as the foundation, builds through HRV coherence as the feedback mechanism, and reaches IHT as the territory available to people who have put the earlier work in. Functional breathing, HRV training, resilience work, and IHT aren't separate offerings. They're the same system at different stages of development.
The progression begins with the Nervous System Assessment and builds through the Resilience Training programme. For people ready to explore the advanced work with supervision, 1:1 coaching is where that happens.
KEY RESEARCH
Low-dose intermittent hypoxic training has demonstrated therapeutic potential across multiple clinical conditions and is supported by growing experimental and clinical evidence.
EPO production and increased red blood cell mass in response to hypoxia are mediated by HIF-1 and represent the primary haematological mechanism of altitude adaptation.
Endogenous nitric oxide produced during nasal breathing and breath holds contributes to vasodilation, bronchodilation, and antimicrobial defence.
NEXT STEPS
Educational content only. Not medical advice. IHT involves significant physiological demand. If any of the contraindications above apply, or if there's any uncertainty about your health status, speak with a qualified medical professional before attempting breath-hold protocols.